Related Experiment Video
Updated: May 5, 2026

Preparation and Characterization of Nanoliposomes for the Entrapment of Bioactive Hydrophilic Globular Proteins
Published on: August 31, 2019
Bioavailability of polyphenol liposomes: a challenge ahead
Nathalie Mignet1, Johanne Seguin, Guy G Chabot
1Chemical, Genetic and Imaging Pharmacology Laboratory (CNRS UMR 8151, INSERM U1022), Faculty of Pharmacy, Paris Descartes University, Sorbonne Paris Cité, Chimie-ParisTech, 4 avenue de l'Observatoire, Paris F-75006, France. nathalie.mignet@parisdescartes.fr.
Dietary polyphenols show promise for cancer prevention but suffer from poor bioavailability. Liposomal formulations are being explored to enhance polyphenol delivery and therapeutic efficacy, overcoming clinical limitations.
Area of Science:
- Nutritional biochemistry
- Nanotechnology
- Pharmacology
Background:
- Dietary polyphenols, including flavonoids, are recognized for their potential in preventing diseases like cancer.
- Poor bioavailability of polyphenols limits their clinical application and therapeutic benefits.
- Liposomes are emerging as a promising delivery system to enhance polyphenol efficacy.
Purpose of the Study:
- To review the challenges associated with polyphenol bioavailability.
- To explore the potential of liposomal formulations in improving polyphenol pharmacokinetics and pharmacodynamics.
- To discuss the advantages and challenges in the development of liposomal polyphenol delivery systems.
Main Methods:
- Literature review focusing on polyphenol bioavailability.
- Analysis of studies on liposomal encapsulation of polyphenols.
- Evaluation of pharmacokinetic and pharmacodynamic improvements offered by liposomes.
- Review of challenges and future directions in liposomal polyphenol development.
Main Results:
- Polyphenols possess significant health benefits, particularly in cancer chemoprevention.
- Poor absorption and rapid metabolism contribute to low polyphenol bioavailability.
- Liposomal encapsulation significantly enhances polyphenol bioavailability, improving therapeutic outcomes.
- Development of liposomal formulations presents challenges but offers substantial therapeutic advantages.
Conclusions:
- Liposomal delivery systems represent a viable strategy to overcome the bioavailability limitations of polyphenols.
- Further research and development in liposomal polyphenol formulations are crucial for their clinical translation.
- Optimized liposomal formulations hold significant promise for enhancing the therapeutic efficacy of polyphenols in disease prevention and treatment.
More Related Videos
08:44Preparation, Administration, and Assessment of In Vivo Tissue-Specific Cellular Uptake of Fluorescent Dye-Labeled Liposomes
Published on: July 30, 2020
07:42Author Spotlight: Development and Characterization of Eco-Friendly Lignin-Based Microparticles for Enhanced Delivery of Bioflavonoids
Published on: March 1, 2024
Related Concept Videos
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Bioavailability Enhancement: Drug Permeability Enhancement
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Bioavailability Enhancement: Drug Solubility Enhancement
Bioavailability: Overview
Bioavailability: Overview